Advances in Alcohol Use Disorder Treatment, Volume 178 in the International Review in Neurobiology series, presents a comprehensive exploration of emerging therapies and approaches in the field. Topics in this new release include Introduction: Current Treatments, Oxytocin and Vasopressin, Neuroactive steroids, Pharmacological activators of ALDH2, Anti inflammatories and mesenchymal stem cells, Sodium oxybate, Psychedelic compounds, Cannabinoids, Environmental Enrichment, Animal models and translational challenges, GABAergic compounds, and Ghrelin system and GLP-1.
Table of Contents
1. Introduction: Current TreatmentsRosana Camarini and Fabio Cardoso Cruz
2. Oxytocin and Vasopressin
Howard C. Becker, Sutton Scarboro and Marcelo Lopez
3. Neuroactive steroids
Leslie Morrow
4. Pharmacological activators of ALDH2
Mario Rivera
5. Anti inflammatories�and mesenchymal stem cells
Fernando Ezquer, Javiera Gallardo and Pablo Berr�os-C�rcamo
6. Sodium oxybate
Julien Guiraud
7. Psychedelic compounds
Eduardo Ary Villela Marinho Sr.
8. Cannabinoids
Cristiane R. Carvalho
9. Environmental Enrichment
Rosana Camarini, Paola Palombo and Regina Noto
10. Animal models and translational challenges
Fabio Cardoso Cruz
11. GABAergic compounds
Lais F. Berro
12. Ghrelin system and GLP-1
Elisabet Jerlhag Holm
